Lack of Relationships between FGF19 Staining Pattern, Lymph Node Metastasis and Locally Invasive Characteristics of the Tumor in Colorectal Cancers |
Unal, Hakan Umit
(Gastroenterology Department, Baskent University Faculty of Medicine)
Demiralay, Ebru (Pathology Department, Baskent University Faculty of Medicine) Tepeoglu, Merih (Pathology Department, Baskent University Faculty of Medicine) Fidan, Cihan (Family Medicine, Baskent University Faculty of Medicine) Kilickap, Saadettin (Preventive Oncology, Hacettepe University Cancer Institute) |
1 | Ainsworth PD, Johnson MA (2010). The prognostic significance of the metastatic lymph node ratio in Dukes stage C colorectal cancer in a district general hospital. Colorectal Dis, 12, 1219-22. DOI ScienceOn |
2 | Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000). American joint committee on cancer prognostic factors consensus conference: colorectal working group. Cancer, 88, 1739-57. DOI ScienceOn |
3 | Desnoyers LR, Pai R, Ferrando RE, et al (2008). Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene, 27, 85-97. DOI ScienceOn |
4 | Engstrom W, Granerus M (2006). Effects of fibroblast growth factors 19 and 20 on cell multiplication and locomotion in a human embryonal carcinoma cell line (Tera-2) in vitro. Anticancer Res, 26, 3307-10. |
5 | Feng S, Dakhova O, Creighton CJ, Ittmann M (2013). Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression. Cancer Res, 73, 2551-62. DOI ScienceOn |
6 | French DM, Lin BC, Wang M, et al (2012). Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One, 7, 36713. DOI |
7 | Gout S, Huot J (2008). Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 1, 69-83. DOI |
8 | Hyeon J, Ahn S, Lee JJ, Song DH, Park CK (2013). Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma. Dig Dis Sci, [Epub ahead of print]. |
9 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
10 | Johnson PM, Porter GA, Ricciardi R, Baxter NN (2006). Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol, 24, 3570-5. DOI ScienceOn |
11 | Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A (2011). Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology, 43, 133-7. DOI ScienceOn |
12 | Katoh M (2006). Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther, 5, 1059-64. DOI |
13 | Lin BC, Desnoyers LR (2012). FGF19 and cancer. Adv Exp Med Biol, 728, 183-94. DOI |
14 | Miyake A, Nakayama Y, Konishi M, Itoh N (2005). Fgf19 regulated by Hh signaling is required for zebrafish forebrain development. Dev Biol, 288, 259-75. DOI ScienceOn |
15 | Nicholes K, Guillet S, Tomlinson E, et al (2002). A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol, 160, 2295-307. DOI ScienceOn |
16 | Ornitz DM (2005). FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev, 16, 205-13. DOI ScienceOn |
17 | Pai R, Dunlap D, Qing J, et al (2008). Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating betacatenin signaling. Cancer Res, 68, 5086-95. DOI ScienceOn |
18 | Quirke P, Williams GT, Ectors N, et al (2007). The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol, 8, 651-7. DOI ScienceOn |
19 | Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg, 248, 968-78. DOI ScienceOn |
20 | Royston D, Jackson DG (2009). Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol, 217, 608-19. DOI ScienceOn |
21 | Siffroi-Fernandez S, Felder-Schmittbuhl MP, Khanna H, Swaroop A, Hicks D (2008). FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro. Invest Ophthalmol Vis Sci, 49, 1696-704. DOI ScienceOn |
22 | Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008). Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol, 15, 1600-8. DOI ScienceOn |
23 | Wu X, Ge H, Lemon B, et al (2010). FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem, 285, 5165-70. DOI ScienceOn |
24 | Xie MH, Holcomb I, Deuel B, et al (1999). FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine, 11, 729-35. DOI ScienceOn |